Corrigendum to 'Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)' EClinicalMedicine 11 (2019) 65-80

EClinicalMedicine. 2020 Jan 10:18:100250. doi: 10.1016/j.eclinm.2019.100250. eCollection 2020 Jan.

Beatriz Mothe^{1

2

3}, Christian Manzardo⁴, Alvaro Sanchez-Bernabeu¹, Pep Coll^{1

2}, Sara Morón-López¹, Maria C Puertas¹, Miriam Rosas-Umbert^{1

5}, Patricia Cobarsi², Roser Escrig², Núria Perez-Alvarez^{2

6}, Irene Ruiz⁴, Cristina Rovira⁴, Michael Meulbroek⁷, Alison Crook⁸, Nicola Borthwick⁸, Edmund G Wee⁸, Hongbing Yang⁹, Jose M Miró⁴, Lucy Dorrell⁹, Bonaventura Clotet^{1

2

3

5}, Javier Martinez-Picado^{1

3

10}, Christian Brander^{1

3

10}, Tomáš Hanke^{8

11}; BCN 01 study group

¹ IrsiCaixa AIDS Research Institute-HIVACAT, Hospital Universitari Germans Trias i Pujol, Crta Canyet s/n, 08916 Badalona, Spain.
² Fundació Lluita contra la Sida, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
³ Universitat de Vic, Universitat Central de Catalunya (UVIC-UCC), Vic, Spain.
⁴ Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.
⁵ Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
⁶ Technical University of Catalonia, Barcelona, Spain.
⁷ Projecte del Noms, BCN Checkpoint, Barcelona, Spain.
⁸ The Jenner Institute, University of Oxford, Oxford, UK.
⁹ Nuffield Department of Medicine and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
¹⁰ ICREA, Pg. Luis Companys 23, Barcelona, Spain.
¹¹ International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan.

Abstract

[This corrects the article DOI: 10.1016/j.eclinm.2019.05.009.].